 |
|
|
| |
Nucleos(t)ide analogue withdrawal in chronic hepatitis B patients leads to limited sustained remission in the absence of HBsAg loss: Results from the RETRACT-B study Response after End of Treatment with Antivirals in Chronic Hepatitis B (RETRACT-B Study)
|
| |
| |
AASLD 2021 Nov 12-16
Grishma Hirode1,2,3, Bettina E Hansen1,3, Chien-Hung Chen4, Tung-Hung Su5, Margarita Papatheodoridi6, Sabela Lens7, Stijn Van Hees8, Sylvia M Brakenhoff9, Hannah SJ Choi1, Rong-Nan Chien10, Wai-Kay Seto11, Grace Wong12, Jordan J Feld1,2,3, Henry LY Chan12, Man-Fung Yuen11, Milan J Sonneveld9, Thomas Vanwolleghem8, Xavier Forns7, George V Papatheodoridis6, Jia-Horng Kao5, Yao-Chun Hsu13, Markus Cornberg14, Wen-Juei Jeng10, Harry LA Janssen1,2,3
1 The Toronto Viral Hepatitis Care Network (VIRCAN), Canada 2 Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Canada 3 Institute of Medical Science, University of Toronto, Canada 4 Kaohsiung Chang Gung Memorial Hospital, Taiwan 5 National Taiwan University Hospital, Taiwan 6 Medical School of National and Kapodistrian University of Athens, Greece 7 Hospital Clinic Barcelona, IDIBAPS and CIBEREHD, University of Barcelona, Spain 8 Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium 9 Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, Netherlands 10 Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital Linkou Medical Center, Chang Gung University, Linkou, Taiwan 11 Department of Medicine and State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, SAR China 12 The Chinese University of Hong Kong, Hong Kong, SAR China 13 E-Da Hospital/I-Shou University, Taiwan 14 Department of Gastroenterology, Hepatolology and Endocrinology, Hannover Medical School, Germany; Centre for Individualized Infection Medicine (CiiM), Hannover, Germany
|
| |
|
|
|
|
|
